Narayan KV, Boyle JP, Thompson TJ, et al. Lifetime risk for diabetes mellitus in the United States. JAMA. 2003;290(14):1884–90.
Shulman GI. Cellular mechanisms of insulin resistance. J ClinInvest. 2000;106(2):171–6.
Warram JH, Martin BC, Krolewski AS, et al. Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents. Ann Intern Med. 1990;113(12):909–15.
Lillioja S, Mott DM, Howard BV, et al. Impaired glucose tolerance as a disorder of insulin action. N Engl J Med. 1988;318(19):1217–25.
McAuley K, Mann J. Thematic review series: patient-oriented research. Nutritional determinants of insulin resistance. J Lipid Res. 2006;47(8):1668–76.
• Sung K-C, Jeong W-S, Wild SH, et al. Combined influence of insulin resistance, overweight/obesity, and fatty liver as risk factors for type 2 diabetes. Diabetes Care. 2012;35(4):717–22. Authors show that clustering of IR, overweight/obesity and fatty liver markedly increases the risk of developing T2DM, with independent effects of the single components.
Vazquez G, Duval S, Jacobs DR, et al. Comparison of body mass index, waist circumference, and waist/hip ratio in predicting incident diabetes: a meta-analysis. Epidemiol Rev. 2007;29(1):115–28.
Moore MC, Cherrington AD, Wasserman DH. Regulation of hepatic and peripheral glucose disposal. Best Pract Res Clin Endocrinol Metab. 2003;17(3):343–64.
Sivaraman S, Weickert MO. Nutrition and exercise in the treatment of type 2 diabetes mellitus. Hamdan Med J. 2012;5(2):131–44.
•• Johnston K, Thomas E, Bell J, et al. Resistant starch improves insulin sensitivity in metabolic syndrome. Diabet Med. 2010;27(4):391–7. Authors show that treatment with resistant starch for 12-wk significantly increases whole-body IR by 15%, as mesured using EHC. This effect would have been missed using markers of IR only, including HOMA %S and HOMA %B.
•• Weickert MO, Roden M, Isken F, et al. Effects of supplemented isoenergetic diets differing in cereal fiber and protein content on insulin sensitivity in overweight humans. Am J Clin Nutr. 2011;94(2):459–71. We show that treatment with isoenergetic diets varying in cereal fiber and protein content for 6 to 18-wk results in significantly and markedly changed whole-body IR (25% difference between groups in M-value), and smaller but significant differences in EGP. These effects would have been missed using markers of IR only, including HOMA-IR and OGIS.
DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979;237(3):E214–23.
Perseghin G, Lattuada G, Danna M, et al. Insulin resistance, intramyocellular lipid content, and plasma adiponectin in patients with type 1 diabetes. Am J Physiol Endocrinol Metab. 2003;285(6):E1174–81.
• Weickert MO. What dietary modification best improves insulin sensitivity and why? Clin Endocrinol. 2012;77(4):508–12. A concise overview of effects of diet on IR.
Pi-Sunyer X, Blackburn G, Brancati F, et al. Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial. Diabetes Care. 2007;30(6):1374–83.
Heshka S, Yang M-U, Wang J, et al. Weight loss and change in resting metabolic rate. Am J Clin Nutr. 1990;52(6):981–6.
Bray G. Effect of caloric restriction on energy expenditure in obese patients. Lancet. 1969;294(7617):397–8.
Nair K, Halliday D, Garrow J. Increased energy expenditure in poorly controlled type 1 (insulin-dependent) diabetic patients. Diabetologia. 1984;27(1):13–6.
Bogardus C, Taskinen M-R, Zawadzki J, et al. Increased resting metabolic rates in obese subjects with non-insulin-dependent diabetes mellitus and the effect of sulfonylurea therapy. Diabetes. 1986;35(1):1–5.
Weickert MO. Nutritional modulation of insulin resistance. Scientifica. 2012. doi:10.6064/2012/424780.
Milne RM, Mann JI, Chisholm AW, et al. Long-term comparison of three dietary prescriptions in the treatment of NIDDM. Diabetes Care. 1994;17(1):74–80.
Kastorini C-M, Milionis HJ, Esposito K, et al. The effect of mediterranean diet on metabolic syndrome and its componentsa meta-analysis of 50 studies and 534,906 individuals. J Am Coll Cardiol. 2011;57(11):1299–313.
Thomas HE, Kay TW. Intracellular pathways of pancreatic β- cell apoptosis in type 1 diabetes. Diabetes/Metabol Res Rev. 2011;27(8):790–6.
Risérus U, Willett WC, Hu FB. Dietary fats and prevention of type 2 diabetes. Prog Lipid Research. 2009;48(1):44–51.
Weickert MO, Pfeiffer AF. Metabolic effects of dietary fiber consumption and prevention of diabetes. J Nutr. 2008;138(3):439–42.
de Munter JS, Hu FB, Spiegelman D, et al. Whole grain, bran, and germ intake and risk of type 2 diabetes: a prospective cohort study and systematic review. PLoS Med. 2007;4(8):e261.
Schulze MB, Schulz M, Heidemann C, et al. Fiber and magnesium intake and incidence of type 2 diabetes: a prospective study and meta-analysis. Arch Intern Med. 2007;167(9):956.
• Sluijs I, Beulens JW, Spijkerman AM, et al. Dietary intake of total, animal, and vegetable protein and risk of type 2 diabetes in the European Prospective Investigation into Cancer and Nutrition (EPIC)-NL study. Diabetes Care. 2010;33(1):43–8. Prospective cohort study in 38,094 participants, suggesting 30% increased Diabetes risk with diets high in animal protein but also in total protein.
Robertson M, Currie J, Morgan L, et al. Prior short-term consumption of resistant starch enhances postprandial insulin sensitivity in healthy subjects. Diabetologia. 2003;46(5):659–65.
Weickert M, Mohlig M, Koebnick C, et al. Impact of cereal fibre on glucose-regulating factors. Diabetologia. 2005;48(11):2343–53.
Freeland KR, Anderson GH, Wolever T. Acute effects of dietary fibre and glycaemic carbohydrate on appetite and food intake in healthy males. Appetite. 2009;52(1):58–64.
Hamedani A, Akhavan T, Samra RA, et al. Reduced energy intake at breakfast is not compensated for at lunch if a high-insoluble-fiber cereal replaces a low-fiber cereal. Am J Clinical Nutr. 2009;89(5):1343–9.
Arai H, Mizuno A, Sakuma M, et al. Effects of a palatinose-based liquid diet (Inslow) on glycemic control and the second-meal effect in healthy men. Metabolism. 2007;56(1):115–21.
Brighenti F, Benini L, Del Rio D, et al. Colonic fermentation of indigestible carbohydrates contributes to the second-meal effect. Am J Clinical Nutr. 2006;83(4):817–22.
Östman EM, Elmståhl HGL, Björck IM. Barley bread containing lactic acid improves glucose tolerance at a subsequent meal in healthy men and women. J Nutr. 2002;132(6):1173–5.
Pacini G, Mari A. Methods for clinical assessment of insulin sensitivity and beta-cell function. Best Pract Res Clin Endocrinol Metab. 2003;17(3):305–22.
Ahren B, Pacini G. Importance of quantifying insulin secretion in relation to insulin sensitivity to accurately assess beta cell function in clinical studies. Eur J Endocrinol. 2004;150(2):97–104.
Muniyappa R, Lee S, Chen H, et al. Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. Am J Physiol Endocrinol Metab. 2008;294(1):E15–26.
Bequette BW. Glucose clamp algorithms and insulin time-action profiles. J Diabetes Sci Technol. 2009;3(5):1005–13.
Furler S, Zelenka G, Kraegen E. Development and testing of a simple algorithm for a glucose clamp. Med Biol Eng Comput. 1986;24(4):365–70.
Clemens AH, Hough DL, D'Orazio PA. Development of the Biostator Glucose clamping algorithm. Clin Chem. 1982;28(9):1899–904.
Catalogna M, Cohen E, Fishman S, et al. Artificial neural networks based controller for glucose monitoring during clamp test. PLoS One. 2012;7(8):e44587.
Sternberg F, Meyerhoff C, Mennel F, et al. Does fall in tissue glucose precede fall in blood glucose? Diabetologia. 1996;39(5):609–12.
Weickert MO, Loeffelholz C, Roden M, et al. A Thr94Ala mutation in human liver fatty acid-binding protein contributes to reduced hepatic glycogenolysis and blunted elevation of plasma glucose levels in lipid-exposed subjects. Am J Physiol Endocrinol Metab. 2007;293(4):E1078–84.
Cherrington A, Edgerton D, Sindelar D. The direct and indirect effects of insulin on hepatic glucose production in vivo. Diabetologia. 1998;41(9):987–96.
Edgerton DS, Cardin S, Emshwiller M, et al. Small increases in insulin inhibit hepatic glucose production solely caused by an effect on glycogen metabolism. Diabetes. 2001;50(8):1872–82.
Williamson JR, Browning ET, Scholz R, et al. Inhibition of fatty acid stimulation of gluconeogenesis by (+)-decanoylcarnitine in perfused rat liver. Diabetes. 1968;17(4):194–208.
Roden M, Stingl H, Chandramouli V, et al. Effects of free fatty acid elevation on postabsorptive endogenous glucose production and gluconeogenesis in humans. Diabetes. 2000;49(5):701–7.
Boden G. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes. 1997;46(1):3–10.
Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care. 1999;22(9):1462–70.
Miyazaki Y, Glass L, Triplitt C, et al. Abdominal fat distribution and peripheral and hepatic insulin resistance in type 2 diabetes mellitus. Am J Physiol Endocrinol Metab. 2002;283(6):E1135–43.
Vangipurapu J, Stančáková A, Kuulasmaa T, et al. A novel surrogate index for hepatic insulin resistance. Diabetologia. 2011;54(3):540–3.
•• Hattersley JG, Möhlig M, Roden M, et al. Quantifying the improvement of surrogate indices of hepatic insulin resistance using complex measurement techniques. PLoS One. 2012;7(6):e39029. We reviewed HEP-IR indices proposed by others and validated them using an independent cohort, using robust methodologies and statistical analyses; in addition to suggesting improved alternative HEP-IR indices.
Hother-Nielsen O, Beck-Nielsen H. On the determination of basal glucose production rate in patients with type 2 (non-insulin-dependent) diabetes mellitus using primed-continuous 3-3H-glucose infusion. Diabetologia. 1990;33(10):603–10.
Landau BR, Wahren J, Chandramouli V, et al. Contributions of gluconeogenesis to glucose production in the fasted state. J Clin Invest. 1996;98(2):378.
Chandramouli V, Ekberg K, Schumann WC, et al. Quantifying gluconeogenesis during fasting. Am J Physiol Endocrinol Metab. 1997;273(6):E1209–15.
Steele R. Influences of glucose loading and of injected insulin on hepatic glucose output*. Ann N Y Acad Sci. 1959;82(2):420–30.
Basu R, Breda E, Oberg AL, et al. Mechanisms of the age-associated deterioration in glucose tolerance contribution of alterations in insulin secretion, action, and clearance. Diabetes. 2003;52(7):1738–48.
Livesey G, Wilson P, Dainty J, et al. Simultaneous time-varying systemic appearance of oral and hepatic glucose in adults monitored with stable isotopes. Am J Physiol Endocrinol Metab. 1998;275(4):E717–28.
Gastaldelli A, Coggan A, Wolfe R. Assessment of methods for improving tracer estimation of non-steady-state rate of appearance. J Appl Physiol. 1999;87(5):1813–22.
Staehr P, Hother-Nielsen O, Landau BR, et al. Effects of free fatty acids per se on glucose production, gluconeogenesis, and glycogenolysis. Diabetes. 2003;52(2):260–7.
Radziuk J, Lickley H. The metabolic clearance of glucose: measurement and meaning. Diabetologia. 1985;28(6):315–22.
Hermans M, Levy J, Morris R, et al. Comparison of insulin sensitivity tests across a range of glucose tolerance from normal to diabetes. Diabetologia. 1999;42(6):678–87.
Legro RS, Finegood D, Dunaif A. A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 1998;83(8):2694–8.
Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412–9.
Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes care, 2004. 27(6):1487–1495. 68. Group, U.P.D.S., UK prospective diabetes study 16. Overview of 6 years’ therapy of type II diabetes: a progressive disease. Diabetes. 1995;44(11):1249–58.
Wallace T, Levy J, Matthews D. An increase in insulin sensitivity and basal beta- cell function in diabetic subjects treated with pioglitazone in a placebo- controlled randomized study. Diabet Med. 2004;21(6):568–76.
Haffner SM, Gonzalez C, Miettinen H, et al. A prospective analysis of the HOMA model: the Mexico City diabetes study. Diabetes Care. 1996;19(10):1138–41.
Levy JC, Matthews DR, Hermans MP. Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care. 1998;21(12):2191–2.
Li X, Zhou Z, Qi H, et al. Replacement of insulin by fasting C-peptide in modified homeostasis model assessment to evaluate insulin resistance and islet beta cell function. J Central South Uni. 2004;29(4):419.
Cobelli C, Toffolo GM, Dalla C. Man, et al., Assessment of β-cell function in humans, simultaneously with insulin sensitivity and hepatic extraction, from intravenous and oral glucose tests. Am J Physiol Endocrinol Metab. 2007;293(1):E1–E15.
Katz A, Nambi SS, Mather K, et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab. 2000;85(7):2402–10.
Mari A, Pacini G, Brazzale A, et al. Comparative evaluation of simple insulin sensitivity methods based on the oral glucose tolerance test. Diabetologia. 2005;48(4):748–51.
Stumvoll M, Mitrakou A, Pimenta W, et al. Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care. 2000;23(3):295–301.
Soonthornpun S, Setasuban W, Thamprasit A, et al. Novel insulin sensitivity index derived from oral glucose tolerance test. J Clin Endocrinol Metab. 2003;88(3):1019–23.
Abdul-Ghani MA, Matsuda M, Balas B, et al. Muscle and liver insulin resistance indexes derived from the oral glucose tolerance test. Diabetes Care. 2007;30(1):89–94.
Jacquez JA. Compartmental analysis in biology and medicine. Ann Arbor: University of Michigan Press; 1985.
Mari A, Pacini G, Murphy E, et al. A model-based method for assessing insulin sensitivity from the oral glucose tolerance test. Diabetes Care. 2001;24(3):539–48.
Bergman RN, Ider YZ, Bowden CR, et al. Quantitative estimation of insulin sensitivity. Am J Physiol. 1979;236(6):E667–77.
Toffolo G, Bergman RN, Finegood DT, et al. Quantitative estimation of beta cell sensitivity to glucose in the intact organism: a minimal model of insulin kinetics in the dog. Diabetes. 1980;29(12):979–90.
De Gaetano A, Arino O. Mathematical modelling of the intravenous glucose tolerance test. J Math Biol. 2000;40(2):136–68.
Pacini G, Bergman RN. MINMOD: a computer program to calculate insulin sensitivity and pancreatic responsivity from the frequently sampled intravenous glucose tolerance test. Comput Methods Programs Biomed. 1986;23(2):113–22.
Levitt DG. PKQuest: a general physiologically based pharmacokinetic model. Introduction and application to propranolol. BMC. Pharmacol Toxicol. 2002;2(1):5.